1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted
2. Executive Summary
2.1. Market Snapshot: Global Contraceptives Market
2.3. Global Contraceptives Market, By Drugs, 2025 (US$ Million)
2.4. Global Contraceptives Market, By Devices, 2025 (US$ Million)
2.5. Global Contraceptives Market, By Geography, 2025 (US$ Million)
2.6. Attractive Investment Proposition by Geography, 2025
3. Contraceptives Market: Competitive Analysis
3.1. Market Positioning of Key Contraceptives Market Vendors
3.2. Strategies Adopted by Contraceptives Market Vendors
4. Contraceptives Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Contraceptives Market Value, 2024 - 2034, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. Porter's Five Force Model
4.5.1. Supplier Power
4.5.2. Buyer Power
4.5.3. Threat Of Substitutes
4.5.4. Threat Of New Entrants
4.5.5. Competitive Rivalry
4.6. PESTEL Analysis
4.6.1. Political Landscape
4.6.2. Economic Landscape
4.6.3. Social Landscape
4.6.4. Technology Landscape
4.6.5. Environmental Landscape
4.6.6. Legal Landscape
5. Contraceptives Market: By Drugs, 2024-2034, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2025 Versus 2034
5.3. Market Segmentation
5.3.1. Contraceptive Pills
5.3.2. Injectable Contraceptives
5.3.3. Topical Contraceptives
6. Contraceptives Market: By Devices, 2024-2034, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2025 Versus 2034
6.3. Market Segmentation
6.3.1. Male Condoms
6.3.2. Female Condoms
6.3.3. Diaphragms
6.3.4. Contraceptive Sponges
6.3.5. Vaginal Rings
6.3.6. Subdermal Implants
6.3.7. Intrauterine Devices
7. North America Contraceptives Market, 2024-2034, USD (Million)
7.1. Market Overview
7.2. Contraceptives Market: By Drugs, 2024-2034, USD (Million)
7.3. Contraceptives Market: By Devices, 2024-2034, USD (Million)
7.4. Contraceptives Market: By Region, 2024-2034, USD (Million)
7.4.1.North America
7.4.1.1. U.S.
7.4.1.1.1. Contraceptives Market: By Drugs, 2024-2034, USD (Million)
7.4.1.1.2. Contraceptives Market: By Devices, 2024-2034, USD (Million)
7.4.1.2. Canada
7.4.1.2.1. Contraceptives Market: By Drugs, 2024-2034, USD (Million)
7.4.1.2.2. Contraceptives Market: By Devices, 2024-2034, USD (Million)
7.4.1.3. Rest of North America
7.4.1.3.1. Contraceptives Market: By Drugs, 2024-2034, USD (Million)
7.4.1.3.2. Contraceptives Market: By Devices, 2024-2034, USD (Million)
8. UK and European Union Contraceptives Market, 2024-2034, USD (Million)
8.1. Market Overview
8.2. Contraceptives Market: By Drugs, 2024-2034, USD (Million)
8.3. Contraceptives Market: By Devices, 2024-2034, USD (Million)
8.4. Contraceptives Market: By Region, 2024-2034, USD (Million)
8.4.1.UK and European Union
8.4.1.1. UK
8.4.1.1.1. Contraceptives Market: By Drugs, 2024-2034, USD (Million)
8.4.1.1.2. Contraceptives Market: By Devices, 2024-2034, USD (Million)
8.4.1.2. Germany
8.4.1.2.1. Contraceptives Market: By Drugs, 2024-2034, USD (Million)
8.4.1.2.2. Contraceptives Market: By Devices, 2024-2034, USD (Million)
8.4.1.3. Spain
8.4.1.3.1. Contraceptives Market: By Drugs, 2024-2034, USD (Million)
8.4.1.3.2. Contraceptives Market: By Devices, 2024-2034, USD (Million)
8.4.1.4. Italy
8.4.1.4.1. Contraceptives Market: By Drugs, 2024-2034, USD (Million)
8.4.1.4.2. Contraceptives Market: By Devices, 2024-2034, USD (Million)
8.4.1.5. France
8.4.1.5.1. Contraceptives Market: By Drugs, 2024-2034, USD (Million)
8.4.1.5.2. Contraceptives Market: By Devices, 2024-2034, USD (Million)
8.4.1.6. Rest of Europe
8.4.1.6.1. Contraceptives Market: By Drugs, 2024-2034, USD (Million)
8.4.1.6.2. Contraceptives Market: By Devices, 2024-2034, USD (Million)
9. Asia Pacific Contraceptives Market, 2024-2034, USD (Million)
9.1. Market Overview
9.2. Contraceptives Market: By Drugs, 2024-2034, USD (Million)
9.3. Contraceptives Market: By Devices, 2024-2034, USD (Million)
9.4. Contraceptives Market: By Region, 2024-2034, USD (Million)
9.4.1.Asia Pacific
9.4.1.1. China
9.4.1.1.1. Contraceptives Market: By Drugs, 2024-2034, USD (Million)
9.4.1.1.2. Contraceptives Market: By Devices, 2024-2034, USD (Million)
9.4.1.2. Japan
9.4.1.2.1. Contraceptives Market: By Drugs, 2024-2034, USD (Million)
9.4.1.2.2. Contraceptives Market: By Devices, 2024-2034, USD (Million)
9.4.1.3. India
9.4.1.3.1. Contraceptives Market: By Drugs, 2024-2034, USD (Million)
9.4.1.3.2. Contraceptives Market: By Devices, 2024-2034, USD (Million)
9.4.1.4. Australia
9.4.1.4.1. Contraceptives Market: By Drugs, 2024-2034, USD (Million)
9.4.1.4.2. Contraceptives Market: By Devices, 2024-2034, USD (Million)
9.4.1.5. South Korea
9.4.1.5.1. Contraceptives Market: By Drugs, 2024-2034, USD (Million)
9.4.1.5.2. Contraceptives Market: By Devices, 2024-2034, USD (Million)
9.4.1.6. Rest of Asia Pacific
9.4.1.6.1. Contraceptives Market: By Drugs, 2024-2034, USD (Million)
9.4.1.6.2. Contraceptives Market: By Devices, 2024-2034, USD (Million)
10. Latin America Contraceptives Market, 2024-2034, USD (Million)
10.1. Market Overview
10.2. Contraceptives Market: By Drugs, 2024-2034, USD (Million)
10.3. Contraceptives Market: By Devices, 2024-2034, USD (Million)
10.4. Contraceptives Market: By Region, 2024-2034, USD (Million)
10.4.1.Latin America
10.4.1.1. Brazil
10.4.1.1.1. Contraceptives Market: By Drugs, 2024-2034, USD (Million)
10.4.1.1.2. Contraceptives Market: By Devices, 2024-2034, USD (Million)
10.4.1.2. Mexico
10.4.1.2.1. Contraceptives Market: By Drugs, 2024-2034, USD (Million)
10.4.1.2.2. Contraceptives Market: By Devices, 2024-2034, USD (Million)
10.4.1.3. Rest of Latin America
10.4.1.3.1. Contraceptives Market: By Drugs, 2024-2034, USD (Million)
10.4.1.3.2. Contraceptives Market: By Devices, 2024-2034, USD (Million)
11. Middle East and Africa Contraceptives Market, 2024-2034, USD (Million)
11.1. Market Overview
11.2. Contraceptives Market: By Drugs, 2024-2034, USD (Million)
11.3. Contraceptives Market: By Devices, 2024-2034, USD (Million)
11.4. Contraceptives Market: By Region, 2024-2034, USD (Million)
11.4.1.Middle East and Africa
11.4.1.1. GCC
11.4.1.1.1. Contraceptives Market: By Drugs, 2024-2034, USD (Million)
11.4.1.1.2. Contraceptives Market: By Devices, 2024-2034, USD (Million)
11.4.1.2. Africa
11.4.1.2.1. Contraceptives Market: By Drugs, 2024-2034, USD (Million)
11.4.1.2.2. Contraceptives Market: By Devices, 2024-2034, USD (Million)
11.4.1.3. Rest of Middle East and Africa
11.4.1.3.1. Contraceptives Market: By Drugs, 2024-2034, USD (Million)
11.4.1.3.2. Contraceptives Market: By Devices, 2024-2034, USD (Million)
12. Company Profile
12.1. Teva Pharmaceutical Industries Limited (Company Overview, Financial Performance, Product Portfolio, Strategic Initiatives)
12.2. Bayer HealthCare AG
12.3. Actavis, Inc.
12.4. Merck & Co., Inc.
12.5. Church & Dwight, Co., Inc.
12.6. CooperSurgical, Inc.
12.7. Reckitt Benckiser plc
12.8. The Female Health Company
12.9. Mayer Laboratories, Inc.
12.10. Other Notable Players
